×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
UPDATED: Acorda inks $185M asset sale to Merz, files for bankruptcy after years of disappointing sales
Fierce Pharma
After years of struggling with hurdles such as generic competition and significantly lower-than-expected sales of its top meds, Acorda...
1 month ago
Acorda Pharmaceuticals in Rockland County NY to shut; 97 jobs lost
Lohud
PEARL RIVER - Acorda Therapeutics, which manufactures key medications used by MS and Parkinson's patients, will lay off all its 97 employees...
1 month ago
Acorda Therapeutics Hits Ch. 11, Plans $185M Drug Sale
Law360
Neurological disorders drugmaker Acorda Therapeutics Inc. filed for Chapter 11 protection in New York bankruptcy court, with plans to sell...
2 months ago
Acorda Therapeutics Announces Delisting from Nasdaq
Business Wire
PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock...
1 month ago
Merz makes a $185m bid for assets from bankrupt Acorda
Pharmaceutical Technology
Merz placed a “stalking horse bid” for Acorda's Parkinson's disease and multiple sclerosis treatments.
2 months ago
Acorda Therapeutics Files for Bankruptcy Protection - WSJ
WSJ
Acorda Therapeutics said it filed for bankruptcy protection and secured a “stalking horse” bid for its assets ahead of an auction process.
2 months ago
Acorda falls 59% as it files for Chapter 11 bankruptcy
Seeking Alpha
Acorda Therapeutics plunges 59% after filing for Chapter 11 bankruptcy, citing debts of $266.2M. Read more here.
2 months ago
Acorda seeks buyer as neurological drug sales fall
Westfair Communications
Rockland County pharmaceutical company Acorda Therapeutics Inc. has declared bankruptcy and is proposing a sale. Acorda and five affiliates...
1 month ago
Acorda Joins Growing Group of Biotechs Filing for Bankruptcy, Divests Assets to Merz
BioSpace
Acorda Therapeutics becomes the latest biotechnology company in 2024 to go bankrupt and shutter its business, following years of financial...
2 months ago